Fundamental Analysis
13 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -4476.9% | -2562.0% | 0 / 3 | -68.0% | -40.66 pp | -31.13 pp | -9.7% | 1.46 | — | 74,1 | −68,0% | −22,9 | −6.304,1% | — | 43.11 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 3.300 (close price on 2026-10-19)EPS (TTM): −1.154,6
Financial charts
1.Revenue & growth
VND bn74,1Q2/26
1.Revenue & growth
VND bn74,1Q2/26
2.Profit & growth
VND bn-22,9Q2/26
3.Profit mix (Penman)
VND bn-33,0Q2/26
4.Margins & cost structure
%4.3%Q2/26
5.Returns & cash cycle
% · days-2.3%Q2/26
6.Earnings quality & cash
VND bn51,5Q2/26
7.Asset structure
VND bn1.083Q2/26
8.Funding & debt health
VND bn · times1.083Q2/26
9.Revenue backlog
VND bn141Q2/26
10.Valuation
times · %-3,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-798Q2/26
Adjusted EPS growth, latest quarter
-4477%
Average adjusted EPS growth, 3 quarters
-2266%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26